standard]
MLLPLIFLILANLSAFVQSQSVCLNNGNYTSNSTYKANLDTVLSSLPTNV
HRNGFYNASFGQNPDRANAIVLCRGDIQLDTCRGCVRDAAAALLASCPNQ
KQAVNWQERCTLRYSNETLVGILATMPGYYWWNPENATSVDQFKEDLSTL
LDDLRGQAVYGGSLRKVAAGNITGPDFQRIFALVQCSPDLSPEDCSSCLI
GAAADIPKCCDRKRGGRVLRPSCTLRFEIYPFYNGTRLEELVPRPEPPVW
PPPEEHGGNTARTVKDDGNSNTTRTVIIITVSVAAGVILVVSVGIFLIKR
IKQKPKDSDHIESEVVDDISTPESLQFAFSTIRDATNNFSDNNKLGQGGF
GTVYKGKFLNGQEIAVKRLSKNSGQGDLEFKNEVLLLARLQHRNLVKLLG
FSLQGEEKLLVYEFVQNASLDLFIFDPINHSYLDWERRHKIIGGIARGIL
YLHEDSRLRIIHRDLKASNVLLDGNMNPKIADFGMARLCGHDETQGNTNR
IVGTYGYMAPEYAIHGQFSVKSDVFSFGVLVLEIISGQKNNCFRSGENVE
DLLSFAWKNWREGTAANVVDPVLRSGAGSMTEMLRCIHIGLLCVQENASD
RPTMASVVLMLSSFSLTLGVPSEPAFYVPSGYGSDVPHFQEYNSIQSDHS
SRNDASITDLHPR
|
IPR000719; Protein kinase, catalytic domain IPR002290; Serine/threonine-protein kinase domain IPR002902; Gnk2-homologous domain IPR008271; Serine/threonine-protein kinase, active site IPR017441; Prote |